Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment
- 21 November 2024
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 144 (21) , 2266-2269
Abstract
Using nanopore sequencing, we showed the feasibility and impact of rapid genomic screening for managing thrombotic microangiopathies in 18 prospective cases, achieving diagnoses in <3 days. We compared the results with standard exome sequencing, cost efficiency, and complement blockade initiation.Keywords
This publication has 18 references indexed in Scilit:
- The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2024
- Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic SyndromeAmerican Journal of Kidney Diseases, 2024
- Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African AncestryKidney International Reports, 2023
- Germline C1GALT1C1 mutation causes a multisystem chaperonopathyProceedings of the National Academy of Sciences, 2023
- Dynamic, adaptive sampling during nanopore sequencing using Bayesian experimental designNature Biotechnology, 2023
- Ultrarapid Nanopore Genome Sequencing in a Critical Care SettingNew England Journal of Medicine, 2022
- Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA2021
- Readfish enables targeted nanopore sequencing of gigabase-sized genomesNature Biotechnology, 2020
- Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B12 TraffickingJournal of Biological Chemistry, 2015
- Atypical aHUS: State of the artMolecular Immunology, 2015